Daumas A, Garros E, Mendizabal H, Gayet S, Bernard F, Bagnères D, Demoux A-L, Rossi P, Villani P, Granel B
Service de médecine interne, gériatrie et thérapeutique, hôpital de la Timone, Aix Marseille université, Assistance publique-Hôpitaux de Marseille (AP-HM), 264, rue Saint-Pierre, 13385 Marseille cedex 05, France.
Service de médecine interne et gériatrie, hôpital Nord, Aix Marseille université, AP-HM, chemin des Bourrely, 13915 Marseille, France.
Rev Med Interne. 2018 Aug;39(8):618-626. doi: 10.1016/j.revmed.2018.03.006. Epub 2018 Apr 5.
Proton pump inhibitors (PPI) are widely prescribed for unrecognized indications, at high a dose and for a long duration, in spite of side effects and numerous drug interactions. In 2009, the HAS (French Health Authority) published recommendations of good prescription but the latter are poorly respected. In this context of over prescription and additional cost for the society, we performed a professional practice evaluation of on the model of the Deming wheel. The objective of this work was to optimize the relevance of the prescriptions of the IPP in two services of internal medicine and geriatrics through an evaluation of the professional practices. All PPI prescriptions introduced in outpatient visits or during hospitalization were analyzed.
Data collection was prospective, over two periods of 2 months and included 163 (first phase), then 139 patients (second phase). An assessment grid of PPI prescriptions was completed by physicians regarding the active substance, the dose, the duration and the indication of the prescription. The relevance of the prescription corresponded to PPI with a conformed indication and duration and to the prescriptions no recommended stopped. Following the first period of data collection, information was given to medical students and physicians on the relevance of their prescriptions with regard to the current recommendations and informative flyers were offered with the aim of improving the practices before the second period of evaluation (second phase).
During the first phase, only 25% of the pre-hospital prescriptions and 33% of the hospital prescriptions respected the HAS recommendations. The main indication of the PPI was the prevention of peptic ulcers in a context of associated drug estimated at risk. An improvement of the global relevance of prescription was observed after awareness of the physicians: 26% relevance during the first phase and 60% in the second one (P<0.012). During the second phase, the part of PPI prescriptions introduced at hospital decreased from 33 to 17% and the discontinuation of the not corresponding prescriptions increased from 6 to 33%, with an additional information given to the general practitioner (P<0.001). However, during the second phase, 33% of the prescriptions introduced in hospitalization were always not corresponding and 61% of the not corresponding prescriptions begun in outpatient visits were always pursued on discharge, probably due to the lack of sufficient information to stop the prescription.
Our study underlines the frequent disrespect of the indications in the prescription of PPI. Interestingly, a professional practices evaluation improved the relevance of the prescriptions with a more frequent withdrawal of the not corresponding exposure and a decrease in global not corresponding prescriptions. Our study suggests that it is crucial to regularly inform physicians on the good prescription of PPI. Patient information focused on the indications and the limited duration of PPI prescription, potentially severe side effects of chronic exposure and on the risk of drug interactions also remains necessary in order to facilitate the stop of the exposure and restrict self-medication.
尽管质子泵抑制剂(PPI)存在副作用和众多药物相互作用,但仍被广泛用于未明确的适应症,且剂量高、疗程长。2009年,法国卫生当局(HAS)发布了合理用药建议,但这些建议未得到充分遵守。在这种过度用药和给社会带来额外成本的背景下,我们基于戴明环模型对专业实践进行了评估。这项工作的目的是通过评估专业实践来优化内科和老年医学两个科室中PPI处方的合理性。对门诊就诊或住院期间开具的所有PPI处方进行了分析。
数据收集是前瞻性的,分两个为期2个月的阶段,第一阶段纳入163例患者,第二阶段纳入139例患者。医生填写了一份PPI处方评估表,内容包括活性物质、剂量、疗程和处方适应症。处方的合理性是指PPI的适应症和疗程符合要求,以及不建议使用的处方已停用。在第一阶段数据收集之后,向医学生和医生提供了关于其处方与当前建议相关性的信息,并提供了信息传单,目的是在第二阶段评估(第二阶段)之前改进实践。
在第一阶段,只有25%的院前处方和33%的住院处方符合HAS建议。PPI的主要适应症是在估计有风险的联合用药情况下预防消化性溃疡。在医生得到相关信息后,处方的整体合理性有所改善:第一阶段为26%,第二阶段为60%(P<0.012)。在第二阶段,住院时开具的PPI处方比例从33%降至17%,不符合要求的处方停用率从6%增至33%,同时向全科医生提供了更多信息(P<0.001)。然而,在第二阶段,33%的住院开具处方仍然不符合要求,61%在门诊开始的不符合要求的处方在出院时仍在继续使用,这可能是由于缺乏足够信息来停用处方。
我们的研究强调了PPI处方中适应症经常未得到遵守的情况。有趣的是,专业实践评估提高了处方的合理性,不适当用药的停用更为频繁,整体不符合要求的处方减少。我们的研究表明,定期向医生通报PPI的合理用药至关重要。为了便于停用药物并限制自我用药,以适应症、PPI处方的有限疗程、长期用药潜在的严重副作用以及药物相互作用风险为重点的患者信息也仍然是必要的。